On August 21-23, 2019, CPhI Korea, the 5th International Pharmaceutical Raw Materials Korea Exhibition, was held in Seoul, Korea. Hangzhou Green Sky Biotechnology Co., Ltd. (referred to as Green Sky Biotechnology) participated in the exhibition.
During the three days of the exhibition, the Green Sky Biological Show attracted many exhibitors to stop, hundreds of catalogue brochures were asked for by interested customers, and our staff have been communicating with the exhibitors with full enthusiasm and earnest attitude.
Korea's pharmaceutical market is one of the most developed pharmaceutical markets in Asia. Its pharmaceutical business investment environment is second only to Japan, ranking second in Asia. According to BMI, the UK International Business Inspection Agency, Korea's drug imports are expected to rise from $3.2 billion in 2008 to $6.4 billion in 2013. Its demand for drugs for chronic diseases and the government's large-scale investment in drug research and development will also greatly increase the demand for raw materials in the country's market. Chinese pharmaceutical companies, which mainly produce and export drugs and generic drugs, will have great opportunities.